CA Stock MarketDetailed Quotes

MBIO MindBio Therapeutics Corp

Watchlist
  • 0.020
  • 0.0000.00%
15min DelayMarket Closed Jan 9 09:30 ET
2.84MMarket Cap-10.00P/E (TTM)

MindBio Therapeutics Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
105.57%20.65K
82.66%-383.47K
95.94%-24.77K
135.68%142.95K
-7.63%-130.61K
65.63%-371.04K
53.16%-2.21M
58.73%-609.88K
75.55%-400.61K
-121.36K
Net income from continuing operations
75.60%-45.82K
90.50%-407.12K
92.80%-244.93K
121.85%65.7K
89.32%-40.12K
10.70%-187.77K
42.65%-4.29M
-15,934.41%-3.4M
92.76%-300.67K
---375.5K
Unrealized gains and losses of investment securities
----
-16.67%14.89K
149.39%130.54K
---115.65K
----
----
--17.87K
---264.33K
--0
----
Remuneration paid in stock
----
--0
----
----
----
----
--1.4M
----
----
----
Other non cashItems
---101.03K
-80.88%181.38K
-90.32%116.85K
168.50%197.55K
----
----
-50.86%948.79K
165.91%1.21M
-112.21%-288.38K
----
Change In working capital
136.27%66.48K
40.35%-172.62K
-106.06%-27.23K
-102.21%-4.16K
172.31%42.03K
78.91%-183.26K
-135.15%-289.39K
35.30%449.43K
26.48%188.43K
---58.12K
-Change in receivables
-107.96%-2.08K
----
----
-1,235.37%-20.58K
-119.23%-3.4K
--26.09K
----
----
99.50%-1.54K
--17.67K
-Change in prepaid assets
----
----
----
--0
----
----
----
----
---36.77K
----
-Change in payables and accrued expense
132.74%68.55K
85.93%-56.97K
-75.50%90.54K
-92.76%16.42K
134.36%45.42K
75.91%-209.36K
-149.20%-405.04K
393.55%369.57K
-50.22%226.74K
---132.22K
-Change in other working capital
----
-200.00%-115.65K
----
----
----
----
--115.65K
----
----
----
Cash from discontinued investing activities
Operating cash flow
78.34%-80.37K
82.66%-383.47K
95.94%-24.77K
135.81%143.45K
-8.03%-131.11K
65.63%-371.04K
53.16%-2.21M
58.73%-609.88K
75.55%-400.61K
---121.36K
Investing cash flow
Cash flow from continuing investing activities
0
0
Net investment purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
--0
----
Financing cash flow
Cash flow from continuing financing activities
-102.81%-8K
-73.82%272.22K
-102.24%-12.61K
0
0
849.44%284.83K
-81.39%1.04M
-48.49%562.4K
-62.76%437.59K
10K
Net issuance payments of debt
---8K
88.28%-12.61K
----
----
----
--0
-101.69%-107.61K
-111.09%-121.09K
-100.69%-26.52K
--10K
Net common stock issuance
----
--0
----
----
----
----
--1.15M
--377.39K
----
----
Net other financing activities
----
--284.83K
--0
--0
--0
--284.83K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-102.81%-8K
-73.82%272.22K
-102.24%-12.61K
--0
--0
849.44%284.83K
-81.39%1.04M
-48.49%562.4K
-62.76%437.59K
--10K
Net cash flow
Beginning cash position
-56.54%138.7K
-105.27%-69.22K
28.43%245.31K
-33.87%101.86K
-12.22%232.97K
-75.72%319.18K
173.92%1.31M
-88.77%191.01K
-92.99%154.03K
--265.39K
Current changes in cash
-2.52%-88.37K
90.50%-111.25K
21.26%-37.38K
287.96%143.45K
-17.73%-131.11K
91.79%-86.2K
-240.31%-1.17M
87.71%-47.48K
107.44%36.98K
---111.36K
Effect of exchange rate changes
----
81.72%319.18K
----
----
----
----
--175.64K
----
----
----
End cash Position
-78.40%50.33K
-56.54%138.7K
-56.54%138.7K
28.43%245.31K
-33.87%101.86K
-12.22%232.97K
-75.72%319.18K
-75.72%319.18K
-88.77%191.01K
--154.03K
Free cash from
78.34%-80.37K
82.66%-383.47K
95.94%-24.77K
135.81%143.45K
-8.03%-131.11K
65.63%-371.04K
53.16%-2.21M
58.73%-609.88K
75.55%-400.61K
---121.36K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 105.57%20.65K82.66%-383.47K95.94%-24.77K135.68%142.95K-7.63%-130.61K65.63%-371.04K53.16%-2.21M58.73%-609.88K75.55%-400.61K-121.36K
Net income from continuing operations 75.60%-45.82K90.50%-407.12K92.80%-244.93K121.85%65.7K89.32%-40.12K10.70%-187.77K42.65%-4.29M-15,934.41%-3.4M92.76%-300.67K---375.5K
Unrealized gains and losses of investment securities -----16.67%14.89K149.39%130.54K---115.65K----------17.87K---264.33K--0----
Remuneration paid in stock ------0------------------1.4M------------
Other non cashItems ---101.03K-80.88%181.38K-90.32%116.85K168.50%197.55K---------50.86%948.79K165.91%1.21M-112.21%-288.38K----
Change In working capital 136.27%66.48K40.35%-172.62K-106.06%-27.23K-102.21%-4.16K172.31%42.03K78.91%-183.26K-135.15%-289.39K35.30%449.43K26.48%188.43K---58.12K
-Change in receivables -107.96%-2.08K---------1,235.37%-20.58K-119.23%-3.4K--26.09K--------99.50%-1.54K--17.67K
-Change in prepaid assets --------------0-------------------36.77K----
-Change in payables and accrued expense 132.74%68.55K85.93%-56.97K-75.50%90.54K-92.76%16.42K134.36%45.42K75.91%-209.36K-149.20%-405.04K393.55%369.57K-50.22%226.74K---132.22K
-Change in other working capital -----200.00%-115.65K------------------115.65K------------
Cash from discontinued investing activities
Operating cash flow 78.34%-80.37K82.66%-383.47K95.94%-24.77K135.81%143.45K-8.03%-131.11K65.63%-371.04K53.16%-2.21M58.73%-609.88K75.55%-400.61K---121.36K
Investing cash flow
Cash flow from continuing investing activities 00
Net investment purchase and sale --------------0------------------0----
Cash from discontinued investing activities
Investing cash flow --------------0------------------0----
Financing cash flow
Cash flow from continuing financing activities -102.81%-8K-73.82%272.22K-102.24%-12.61K00849.44%284.83K-81.39%1.04M-48.49%562.4K-62.76%437.59K10K
Net issuance payments of debt ---8K88.28%-12.61K--------------0-101.69%-107.61K-111.09%-121.09K-100.69%-26.52K--10K
Net common stock issuance ------0------------------1.15M--377.39K--------
Net other financing activities ------284.83K--0--0--0--284.83K----------------
Cash from discontinued financing activities
Financing cash flow -102.81%-8K-73.82%272.22K-102.24%-12.61K--0--0849.44%284.83K-81.39%1.04M-48.49%562.4K-62.76%437.59K--10K
Net cash flow
Beginning cash position -56.54%138.7K-105.27%-69.22K28.43%245.31K-33.87%101.86K-12.22%232.97K-75.72%319.18K173.92%1.31M-88.77%191.01K-92.99%154.03K--265.39K
Current changes in cash -2.52%-88.37K90.50%-111.25K21.26%-37.38K287.96%143.45K-17.73%-131.11K91.79%-86.2K-240.31%-1.17M87.71%-47.48K107.44%36.98K---111.36K
Effect of exchange rate changes ----81.72%319.18K------------------175.64K------------
End cash Position -78.40%50.33K-56.54%138.7K-56.54%138.7K28.43%245.31K-33.87%101.86K-12.22%232.97K-75.72%319.18K-75.72%319.18K-88.77%191.01K--154.03K
Free cash from 78.34%-80.37K82.66%-383.47K95.94%-24.77K135.81%143.45K-8.03%-131.11K65.63%-371.04K53.16%-2.21M58.73%-609.88K75.55%-400.61K---121.36K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.